Capital Directions Investment Advisors, LLC Novo Nordisk A S Transaction History

Capital Directions Investment Advisors, LLC

$268 Million
Q4 2022

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2019 Feb 05, 2020	SELL	$49.86 - $58.26 $8,476 - $9,904	-170 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$47.54 - $53.43 $8,081 - $9,083	170 New	170 $9,000

Others Institutions Holding NVO

# of Institutions

1,988

Shares Held

318M

Call Options Held

5.16M

Put Options Held

4.97M

Jennison Associates LLC

21.2M
Shares

$2.44 Billion
1.95% of portfolio
Morgan Stanley New York, NY

14.6M
Shares

$1.68 Billion
0.16% of portfolio
Bank Of America Corp Charlotte, NC

14.2M
Shares

$1.63 Billion
0.18% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

13.4M
Shares

$1.54 Billion
0.83% of portfolio
Fayez Sarofim & CO Houston, TX

12.6M
Shares

$1.44 Billion
4.91% of portfolio

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $260B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Directions Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Directions Investment Advisors, LLC with notifications on news.

Account